Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study-Reference-Cited by-同舟云学术

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study

Published:2014-08 Issue:2 Volume:61 Page:228-234
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Younossi Zobair M.,Stepanova Maria,Zeuzem Stefan,Dusheiko Geoffrey,Esteban Rafael,Hezode Christophe,Reesink Hendrik W.,Weiland Ola,Nader Fatema,Hunt Sharon L.

Publisher

Elsevier BV

Subject

Hepatology

Reference24 articles.

1. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

2. The burden of hepatitis C in Europe from the patients’ perspective: a survey in 5 countries;Vietri;BMC Gastroenterol,2013

3. Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States;Younossi;Clin Gastroenterol Hepatol,2010

4. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

5. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal clinically important differences in health-related quality of life after treatment with direct-acting antivirals for chronic hepatitis C: ANRS CO22 HEPATHER cohort (PROQOL-HCV);Quality of Life Research;2024-04-05

2. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología;2023-05

3. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología (English Edition);2023-05

4. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial);JHEP Reports;2023-03

5. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use;International Journal of Drug Policy;2023-01